Has the Corinth Group Ever Funded a Deal?

Despite more than a decade of operations under various entity names, no evidence of a completed, funded investment transaction by any Corinth Group entity has been identified in public records. Two major deals were publicly announced, and both show significant discrepancies between announcement and outcome. [Source: Public records analysis]

The Morepen Laboratories Deal (India)

In April 2021, Corinth Investment Holdings AG received approval from SEBI/BSE/NSE for a 9.31% equity stake in Morepen Laboratories Ltd, an Indian pharmaceutical company listed on BSE and NSE. This deal generated significant media coverage, with news outlets describing Corinth as "a global private investment Group based in Switzerland." However, as of December 2025, Corinth Investment Holdings AG does not appear in Morepen's shareholding pattern. The share allotment was processed at the registrar level, but the shares appear to have been transferred or the transaction was otherwise unwound. The reasons for this discrepancy between the announced investment and the current shareholding require investigation. [Source: BSE/NSE announcements, Morepen annual reports, SEBI filings]

The Addvalue Technologies Deal (Singapore)

Pytheas announced a $64 million acquisition of Addvalue Technologies, a Singapore-listed technology company. No evidence has been found that this deal was completed. No SGX substantial shareholding notices have been found linking Pytheas to Addvalue Technologies. Pytheas (Cyprus) Limited (HE 159209) is now dissolved. [Source: SGX announcements, Cyprus company registry]

What Complainants Report

Multiple independent complainants describe a pattern where large, headline-worthy deals are announced — creating an appearance of institutional credibility — while multiple complainants describe a pattern of collecting advance fees from prospective investors under cost contribution agreements and term sheets. The discrepancy between publicly announced deal values ($100M+ for Morepen, $64M for Addvalue) and the reported experience of advance-fee collection ($80K–$1.5M per complainant) is documented across multiple independent sources. [Source: Ripoff Report, Diebewertung.de]

Pinfold Overseas Limited

Pinfold Overseas Limited appears as a 7.03% shareholder of Morepen Laboratories in recent filings. Whether this entity is connected to the Corinth network and whether it represents a transfer of the Corinth-approved shares requires further investigation. [Source: Morepen shareholding pattern, BSE filings]

Related People

Related Entities

Related Investigations

Related Questions